Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0037 | 0.0305 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.0729 | 0.3963 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0098 | 0.3424 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.0729 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0098 | 0.3424 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0037 | 0.0305 | 0.4182 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0037 | 0.0305 | 0.089 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0037 | 0.0305 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0037 | 0.0305 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0035 | 0.0228 | 0.0667 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0067 | 0.1839 | 0.5371 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0035 | 0.0228 | 0.0667 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0035 | 0.0228 | 0.0667 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0035 | 0.0228 | 0.1241 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.0729 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.0035 | 0.0228 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.0729 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0228 | 0.0667 |
Schistosoma mansoni | ap endonuclease | 0.0037 | 0.0305 | 0.1657 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0228 | 0.0667 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0037 | 0.0305 | 0.5 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0037 | 0.0305 | 1 |
Onchocerca volvulus | 0.0035 | 0.0228 | 0.5 | |
Schistosoma mansoni | ap endonuclease | 0.0037 | 0.0305 | 0.1657 |
Toxoplasma gondii | exonuclease III APE | 0.0037 | 0.0305 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0035 | 0.0228 | 0.5 |
Brugia malayi | beta-lactamase | 0.0035 | 0.0228 | 0.0667 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0037 | 0.0305 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.0729 | 0.2129 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0037 | 0.0305 | 1 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0035 | 0.0228 | 0.3133 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0037 | 0.0305 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0098 | 0.3424 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.0729 | 0.2129 |
Onchocerca volvulus | 0.0035 | 0.0228 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.0067 | 0.1839 | 1 |
Loa Loa (eye worm) | beta-lactamase | 0.0035 | 0.0228 | 0.0667 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0098 | 0.3424 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0037 | 0.0305 | 0.5 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0037 | 0.0305 | 0.089 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0228 | 0.0667 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0228 | 0.0667 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0037 | 0.0305 | 0.4182 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.0729 | 0.3963 |
Brugia malayi | beta-lactamase family protein | 0.0035 | 0.0228 | 0.0667 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.0729 | 0.3963 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0228 | 0.0667 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0037 | 0.0305 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0228 | 0.0667 |
Onchocerca volvulus | 0.0035 | 0.0228 | 0.5 | |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0037 | 0.0305 | 0.0078 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.0729 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.1839 | 0.5371 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0037 | 0.0305 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0035 | 0.0228 | 0.3133 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0035 | 0.0228 | 0.1241 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0037 | 0.0305 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0037 | 0.0305 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition frequency index (IFI) (functional) | = 15.85 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 5 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 100 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 100 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 101 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
XC50 (functional) | = 6.12 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.